MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Potential treatment for CMT2S caused by IGHMBP2 cryptic splice variant, with ASO based therapeutic

    S. Smieszek, C. Tyner, A. Kaden, C. Johnson, C. Polymeropoulos, G. Birznieks, M. Polymeropoulos (Washington, USA)

    Objective: Our objective was to target a specific cryptic splice site variant affecting immunoglobulin mu‐binding protein 2 (IGHMBP2) protein levels with a novel antisense oligonucleotide…
  • 2023 International Congress

    Dance for Parkinson’s disease to improve gait and balance: clinical assessments vs. objective measures.

    HHN. Kalyani, K. Sullivan, G. Moyle, S. Brauer, E. Jeffrey, G. Kerr (Colombo, Sri Lanka)

    Objective: To evaluate how the dance classes based on the Dance for Parkinson’s Disease®(DfPD®) model could improve gait and balance in people with Parkinson’s disease…
  • 2023 International Congress

    Update on the ADOPTION Study: Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson’s Disease

    J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

    Objective: This exploratory trial aims to compare treatment outcomes of adding one daily dose of opicapone (OPC) 50 mg versus an additional dose of levodopa…
  • 2023 International Congress

    Functional connectivity fingerprints in Parkinson’s disease patients with hallucinations

    S. Stampacchia, F. Bernasconi, J. Potheegadoo, J. Pagonabarraga, J. Kulisevsky, D. van Deville, E. Amico, O. Blanke (Geneve, Switzerland)

    Objective: Investigate functional connectivity (FC) fingerprints of Minor Hallucinations (MH) in Parkinson’s Disease (PD). Background: MHs occur at the early stages of Parkinson’s disease in…
  • 2023 International Congress

    Case report on the use of a High Frequency Vibrotactile Stimulation and Cueing Device over 4 months in a patient with Parkinson’s Disease and refractory symptoms

    A. Mackett (Cambridge, United Kingdom)

    Objective: To document motor symptoms of a patient with PD whilst using a Focussed Vibrotactile Stimulation and Cueing Device (FVCD). Background: A 77-year-old patient with…
  • 2023 International Congress

    Genetic study of early-onset Parkinson’s disease in the Malaysian population

    YW. Tay, AH. Tan, JL. Lim, K. Lohmann, K. Azmi Ibrahim, Z. Abdul Aziz, YT. Chin, AS. Mawardi, TT. Lim, I. Looi, YK. Chia, JCE. Ooi, WK. Cheah, A. Dy Closas, LC. Lit, JW. Hor, TS. Toh, K. Muthusamy, P. Bauer, V. Skrahin, A. Rolfs, C. Klein, A. Ahmad-Annuar, SY. Lim (Kuala Lumpur, Malaysia)

    Objective: This study aimed to investigate the genetic architecture of EOPD in a multi-ethnic Malaysian cohort. Background: About 5-10% of Parkinson’s disease (PD) cases are…
  • 2023 International Congress

    Validating A New Writer’s Cramp Impairment Scale

    E. Shamim, G. Stebbins, B. Hodsdon, K. Alter, B. Karp, O. Ahmad, P. Srivanitchapoom, K. Mente, C. Toro, S. Meunier, M. Hallett (Rockville, USA)

    Objective: A new writer’s cramp impairment scale (WCIS) was created and is compared with the existing writer’s cramp rating scale (WCRS). Background: Writer’s cramp (WC)…
  • 2023 International Congress

    The efficacy of transcutaneous tibial nerve stimulation for Parkinson’s urinary problems: A Systematic review

    A. Ibrahim Abdelhamed, A. Salah, M. Salama, S. Ezz, H. Samy, N. Karam, O. Hazem, H. Hossam, H. Ahmed, Y. Hamayel, M. Ramadan, M. Emad Fahmy, M. Shafiek Saleh (Elfashn, Egypt)

    Objective: This systematic review summarizes all the published outcomes of urinary problems affecting the quality of life for patients with Parkinson’s disease. Background: The urinary…
  • 2023 International Congress

    Drooling is associated with disease severity in Parkinson’s disease

    N. Nishikawa, E. Ikami, H. Takeshige, T. Ogawa, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: To investigate frequency of PD patients with symptoms of drooling and their clinical characteristics in our Japanese Parkinson's disease (PD) registry data. Background: Drooling…
  • 2023 International Congress

    Parkinsonian tremor secondary to Sinking flap syndrome – An atypical presentation

    R. Kota, K. Garg, M. Singh, R. Rajan (NEW DELHI, India)

    Objective: The association of sinking flap syndrome with Parkinsonian tremors is very rare Background: The association of sinking flap syndrome with Parkinsonian tremors is very…
  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley